Regional, Big U.S. And Global Banks Shake From SVB Collapse On Wednesday
Bank stocks have been suffering since the collapse last week of SVB Financial Group (NASDAQ:SIVB), also known as…
Net Interest Margin (NIM) – What Happened At Silicon Valley Bank And SVB ETF Exposure
Net interest margin (NIM) is a measure of profitability used to evaluate how much money a financial institution makes from the difference between the interest income it earns on its assets and the interest it pays out to its lenders (such as depositors and bondholders) for its liabilities.
Pliant Therapeutics Announces Positive DSMB Safety Review And Initiation of Enrollment Of Phase 2a Trial of Bexotegrast (PLN-74809) at 320 mg Dose In Primary Sclerosing Cholangitis
Bexotegrast, is an oral, small molecule, dual-selective inhibitor of αvβ6 and αvβ1 integrins being developed for the treatment of PSC and idiopathic pulmonary fibrosis (IPF). Bexotegrast has been
Rivian Seems To Be Lacking The EV Luster
On Tuesday, shares of Rivian Automobile Inc (NASDAQ: RIVN) fell as EV maker revealed late Monday it is looking to raise $1.3 billion in cash via a sale of convertible notes amid growing demand concerns.
Cloopen Announces ADS Ratio Change
Cloopen Group Holding Limited (NYSE:RAAS) ("Cloopen" or the "Company") today announced that it will change the ratio of its American depositary shares ("ADSs") to Class A ordinary shares
Major League Soccer Extends Partnership With Adidas Heading Into The 2023 Season
Adidas AG - ADR (OTC: ADDYY) is extending its partnership with Major League Soccer.
The athletic apparel company signed a multi-year extension with the MLS to continue serving as the league's official supplier ahead of the upcoming season.
Higher Interest Rates, The Fed and Getting Back on the (S)ARK
St. Louis Federal Reserve President James Bullard expressed confidence that the Fed can beat inflation and advocated for a more aggressive interest rate hike to combat it. Bullard believes that a more aggressive move now would give the Federal Open Market Committee a better chance to bring down inflation, which is still high despite falling from its levels in 2022.
Takeda Earlier Announced Results from Phase 3 Study of Vedolizumab for Prevention of Intestinal Acute Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
The Phase 3 GRAPHITE Study Met Its Primary Efficacy Endpoint of Significant and Clinically Meaningful Intestinal aGvHD-Free Survival as Compared to Placebo by Day 180 after Allo-HSCT.
No New Safety Signals Were Seen
Jack Ma Reportedly Spotted In Australia: Alibaba Co-Founder Resumes Globetrotting As China’s Regulatory Pressure Eases
Billionaire Jack Ma, who maintained a low profile amid China’s regulatory crackdown, has since late 2022 gradually resumed…
3 Stocks At An Inflection Point
With consumer and producer prices surprising to the upside, multiple research outlets are starting to call for more…